GIẢI NOBEL Y SINH NĂM 2025 VÀ NHỮNG PHÁT HIỆN QUAN TRỌNG VỀ VAI TRÒ CỦA TẾ BÀO T ĐIỀU HOÀ (TREG)

Objective: To systemize the historical trajectory, publication trends, molecular mechanisms, and clinical strategies regarding regulatory T cells (Tregs) - a breakthrough achievement honored with the 2025 Nobel Prize in Physiology or Medicine.Search Methodology and Literature Review: A historical review combined with bibliometrics analysis was conducted. Data were systematically retrieved and synthesized from landmark publications (1990–2026) indexed in PubMed and Scopus databases, utilizing established Medical Subject Headings (MeSH terms: T-Lymphocytes, Regulatory, FOXP3) and free-text keywords (Treg, CAR-Tregs).Results: The modern era of Treg research was established by the identification of the CD4+CD25+ phenotype (1995) and the master control gene FOXP3 (2001–2003). Publications on Tregs experienced exponential growth after 2003 (~7,000–7,300 papers/year), while the transplantation sector has maintained a steady output of ~2,000 papers/year since 2010. Tregs operate via six distinct mechanisms: cytokine secretion, CD39/CD73 axis, CTLA-4 signaling, tissue adaptation, CNS2 epigenetics, and pTreg induction. Treg deficiency drives autoimmunity and transplant rejection, whereas its accumulation within the tumor microenvironment mediates resistance to immune checkpoint inhibitors. Currently, over 200 clinical trials are exploring Treg-based therapeutics, notably low-dose IL-2 (rezpegaldesleukin), autologous Treg transfer, CDK8/19 inhibition, anti-CCR8, and CAR-Tregs.Conclusion: The 2025 Nobel Prize marks the dawn of Treg-based precision medicine centered on regulatory T cells. Modulating Treg functions holds transformative potential to reshape the therapeutic landscape of autoimmune diseases, transplants, and oncology.

Authors

Publication Details

Journal
Journal of Clinical Medicine Bach Mai Hospital
Published
2026-11-21
DOI
https://doi.org/10.52322/jocmbmh.156.0301
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GIẢI NOBEL Y SINH NĂM 2025 VÀ NHỮNG PHÁT HIỆN QUAN TRỌNG VỀ VAI TRÒ CỦA TẾ BÀO T ĐIỀU HOÀ (TREG)

Thị Minh Hằng Trần
Journal of Clinical Medicine Bach Mai Hospital
T-cell and B-cell Immunology
article

GIẢI NOBEL Y SINH NĂM 2025 VÀ NHỮNG PHÁT HIỆN QUAN TRỌNG VỀ VAI TRÒ CỦA TẾ BÀO T ĐIỀU HOÀ (TREG)

Thị Minh Hằng Trần
article en

Abstract

Objective: To systemize the historical trajectory, publication trends, molecular mechanisms, and clinical strategies regarding regulatory T cells (Tregs) - a breakthrough achievement honored with the 2025 Nobel Prize in Physiology or Medicine.Search Methodology and Literature Review: A historical review combined with bibliometrics analysis was conducted. Data were systematically retrieved and synthesized from landmark publications (1990–2026) indexed in PubMed and Scopus databases, utilizing established Medical Subject Headings (MeSH terms: T-Lymphocytes, Regulatory, FOXP3) and free-text keywords (Treg, CAR-Tregs).Results: The modern era of Treg research was established by the identification of the CD4+CD25+ phenotype (1995) and the master control gene FOXP3 (2001–2003). Publications on Tregs experienced exponential growth after 2003 (~7,000–7,300 papers/year), while the transplantation sector has maintained a steady output of ~2,000 papers/year since 2010. Tregs operate via six distinct mechanisms: cytokine secretion, CD39/CD73 axis, CTLA-4 signaling, tissue adaptation, CNS2 epigenetics, and pTreg induction. Treg deficiency drives autoimmunity and transplant rejection, whereas its accumulation within the tumor microenvironment mediates resistance to immune checkpoint inhibitors. Currently, over 200 clinical trials are exploring Treg-based therapeutics, notably low-dose IL-2 (rezpegaldesleukin), autologous Treg transfer, CDK8/19 inhibition, anti-CCR8, and CAR-Tregs.Conclusion: The 2025 Nobel Prize marks the dawn of Treg-based precision medicine centered on regulatory T cells. Modulating Treg functions holds transformative potential to reshape the therapeutic landscape of autoimmune diseases, transplants, and oncology.

Journal of Clinical Medicine Bach Mai HospitalVol. 3(156)
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon